Skip to main content

Most Popular in News

Most Recent

FDA approves generic Xarelto

FDA approves generic Xarelto

There’s a new—hopefully, lower cost—option for people who take anticoagulants to manage heart disease
FDA stamp - Merilog

FDA approves rapid-acting insulin biosimilar

Merilog works like NovoLog to help control blood sugar when injected five to ten minutes before meals
An FDA approval stamp for the approval of Ozempic and kidney function

Ozempic for kidney disease

This diabetes medication is now indicated to prevent the worsening of kidney disease, kidney failure, and death due to cardiovascular disease
victoza generic - FDA approval

FDA approves first generic once-daily GLP-1

Liraglutide, the generic of Victoza, is now available to treat Type 2 diabetes, alongside diet and exercise
Zepbound obstructive sleep apnea - FDA stamp

Zepbound for sleep apnea

It’s the first medication that reduces symptom severity, reducing breathing interruptions at night
FDA stamp - FDA warning compounded semaglutide

FDA issues warning to GLP-1 compounders

The U.S. Food and Drug Administration is sounding the alarm about the risks of taking unapproved versions of Ozempic, Wegovy, Zepbound, and Mounjaro
Neffy - FDA approval

FDA approves epinephrine nasal spray

Neffy is the first needle-free epinephrine to treat life-threatening anaphylaxis
Pivya FDA approval

New Rx approved for simple UTIs

Adult women now have another antibiotic option for this common condition
A stamp for FDA approval - naloxone OTC

Wegovy use expanded by FDA

This expanded approval provides a new indication for the popular weight loss medication
Jubbonti-Wyost - FDA approval

Prolia biosimilar approved

These biologic alternatives signal more affordable options for the pricey injectable medications
Clipboard with charts: Lung cancer statistics

Lung cancer statistics 2024

Each year, 230,000 new cases of lung cancer are diagnosed. Get updated lung cancer statistics here.
1 2 3 18